Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
American Journal of Obstetrics and Gynecology
|
November 4, 2017
First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume
Jiri Sonek, David Krantz, Jon Carmichael, et al.
Scandinavian Journal of Immunology
|
August 31, 2020
IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity
David Krantz, Michael Mints, Malin Winerdal, et al.
Obstetrics and Gynecology
|
July 2, 2004
Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss
Laura Goetzl, David Krantz, Joe Leigh Simpson, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
April 7, 2019
Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder
Juliana Corlier, Andrew Wilson, Aimee M Hunter, et al.
Psychological Medicine
|
June 22, 2021
Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers
Juliana Corlier, Reza Tadayonnejad, Andrew C Wilson, et al.
Plos One
|
July 3, 2018
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway
Ciputra Adijaya Hartana, Emma Ahlén Bergman, A Ali Zirakzadeh, et al.
European Urology
|
July 21, 2018
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer
David Krantz, Ciputra Adijaya Hartana, Malin E Winerdal, et al.
Journal of Psychiatry & Neuroscience : JPN
|
June 15, 2019
Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy
Jennifer G. Levitt, Guldamla Kalender, Joseph O’Neill, et al.
Journal of Affective Disorders
|
July 12, 2023
Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD)
Cole Citrenbaum, Juliana Corlier, Doan Ngo, et al.
Psychiatry Research
|
September 26, 2022
Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder
Reza Tadayonnejad, Andrew C Wilson, Stephanie Anne Chu, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
American Journal of Obstetrics and Gynecology
|
November 4, 2017
First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume
Jiri Sonek, David Krantz, Jon Carmichael, et al.
Scandinavian Journal of Immunology
|
August 31, 2020
IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity
David Krantz, Michael Mints, Malin Winerdal, et al.
Obstetrics and Gynecology
|
July 2, 2004
Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss
Laura Goetzl, David Krantz, Joe Leigh Simpson, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
April 7, 2019
Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder
Juliana Corlier, Andrew Wilson, Aimee M Hunter, et al.
Psychological Medicine
|
June 22, 2021
Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers
Juliana Corlier, Reza Tadayonnejad, Andrew C Wilson, et al.
Plos One
|
July 3, 2018
Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway
Ciputra Adijaya Hartana, Emma Ahlén Bergman, A Ali Zirakzadeh, et al.
European Urology
|
July 21, 2018
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer
David Krantz, Ciputra Adijaya Hartana, Malin E Winerdal, et al.
Journal of Psychiatry & Neuroscience : JPN
|
June 15, 2019
Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy
Jennifer G. Levitt, Guldamla Kalender, Joseph O’Neill, et al.
Journal of Affective Disorders
|
July 12, 2023
Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD)
Cole Citrenbaum, Juliana Corlier, Doan Ngo, et al.
Psychiatry Research
|
September 26, 2022
Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder
Reza Tadayonnejad, Andrew C Wilson, Stephanie Anne Chu, et al.
Page
of 6